Literature DB >> 15710000

A regional audit of iatrogenic perforation of tumours of the oesophagus and cardia.

P Jethwa1, A Lala, J Powell, C C McConkey, E W Gillison, R T Spychal.   

Abstract

INTRODUCTION: With the rising incidence of oesophageal cancer, palliative treatment has an increasingly important role. With median survival unlikely to exceed 6 months, in advanced disease the palliative therapy chosen must not hasten patient's demise. AIM: To establish the outcome of both modern and historical palliative treatment in oesophageal tumours, with emphasis on the aetiology and outcome of iatrogenic perforation.
METHODS: Patients with oesophageal or cardia carcinoma treated within the West Midlands between 1992 and 1996 were identified retrospectively. Information was gathered from hospital case notes and the regional cancer intelligence unit with hospitals visited to capture data. All episodes were entered into a dedicated database.
RESULTS: Of the 3660 patients who were treated, 2529 received palliation as primary treatment, with 5259 palliative procedures performed; 164 iatrogenic perforations were recorded; 83 were due to diagnostic endoscopy (endoscopic perforation) with the reminder due to interventional palliative procedures. Median survival from all forms of palliation was 138 days. Following perforation survival was 95 days after interventional palliative procedure and 58 days after endoscopic perforation (P > 0.05). Thirty-day mortality after emergency surgery was 11.8% with mean survival of 7.5 months.
CONCLUSION: Perforation at diagnostic endoscopy is associated with substantial mortality despite rapid intervention. Patients with suspected cancer must be investigated with extreme care to reduce iatrogenic complications.

Entities:  

Mesh:

Year:  2005        PMID: 15710000     DOI: 10.1111/j.1365-2036.2005.02324.x

Source DB:  PubMed          Journal:  Aliment Pharmacol Ther        ISSN: 0269-2813            Impact factor:   8.171


  6 in total

Review 1.  Current treatment and outcome of esophageal perforations in adults: systematic review and meta-analysis of 75 studies.

Authors:  Fausto Biancari; Vito D'Andrea; Rosalba Paone; Carlo Di Marco; Grazia Savino; Vesa Koivukangas; Juha Saarnio; Ersilia Lucenteforte
Journal:  World J Surg       Date:  2013-05       Impact factor: 3.352

2.  Endoscopic ultrasound staging of stenotic esophageal cancers may be unnecessary to determine the need for neoadjuvant therapy.

Authors:  Stephanie G Worrell; Daniel S Oh; Christina L Greene; Steven R Demeester; Jeffrey A Hagen
Journal:  J Gastrointest Surg       Date:  2013-11-05       Impact factor: 3.452

3.  Palliative cardia resection with gastroesophageal reconstruction for perforated carcinoma of the gastroesophageal junction.

Authors:  Sonja Gillen; Helmut Friess; Jörg Kleeff
Journal:  World J Gastroenterol       Date:  2009-06-28       Impact factor: 5.742

4.  Endoscopic palliation of advanced esophageal cancer.

Authors:  A Mocanu; R Bârla; P Hoara; S Constantinoiu
Journal:  J Med Life       Date:  2015 Apr-Jun

5.  Health-Care Utilization and Complications of Endoscopic Esophageal Dilation in a National Population.

Authors:  Abhinav Goyal; Kshitij Chatterjee; Sujani Yadlapati; Shailender Singh
Journal:  Clin Endosc       Date:  2017-03-17

6.  Clinical implications of endoscopic ultrasonography non-traversability in patients with locoregional esophageal cancer receiving multimodality therapy.

Authors:  Charles J Cho; Ho June Song; Gin Hyug Lee; Kee Don Choi; Yong-Hee Kim; Jin-Sook Ryu; Sung-Bae Kim; Jong Hoon Kim; Seung-Il Park; Hwoon-Yong Jung
Journal:  Korean J Intern Med       Date:  2016-03-14       Impact factor: 2.884

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.